Do chronic myeloid leukemia patients with late 'warning' responses benefit from 'watch and wait' or switching therapy to a second generation tyrosine kinase inhibitor?

Details

Language :

English

ISSN :

03618609

Volume :

89

Issue :

11

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

98899745

Full Text :

https://doi.org/10.1002/ajh.23816